Priority Date: 21.03.12 (EP 20120160643)

NOVEL THERAPEUTIC TARGET FOR THE PREVENTION OF TUMOUR METASTASIS

  • Application ID: EP13710880
  • Status: GRANT OF PATENT INTENDED

Attorney

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 171 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 21.03.2012 - Priority Date (EP 20120160643)
  • 26.09.2013 - Publication A1 (WO2013139940)
  • 28.01.2015 - Publication A1 (EP2828387)

IPC Classification